Overview of metabolism and bioavailability enhancement of polyphenols

Journal of Agricultural and Food Chemistry

Volumn 61, Issue 50, 2013, Pages 12183-12199

  Lewandowska, Urszula ^a   Szewczyk, Karolina ^a   Hrabec, Elzìbieta ^a   Janecka, Anna ^a   Gorlach, Sylwia ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

absorption; bioavailability; metabolism; polyphenols

Indexed keywords

BIOAVAILABILITY; BIOAVAILABILITY ENHANCEMENTS; FRUITS AND VEGETABLES; HEALTH BENEFICIAL EFFECTS; METABOLIC TRANSFORMATIONS; PATENT APPLICATIONS; PHENOLIC COMPOUNDS; POLYPHENOLS;

ABSORPTION; BIOACTIVITY; PHYSIOLOGY;

METABOLISM;

PLANT EXTRACT; POLYPHENOL;

ANIMAL; BIOAVAILABILITY; CLINICAL TRIAL (TOPIC); HUMAN; METABOLISM; REVIEW;

ANIMALS; BIOLOGICAL AVAILABILITY; CLINICAL TRIALS AS TOPIC; HUMANS; PLANT EXTRACTS; POLYPHENOLS;

EID: 84890696397     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf404439b     Document Type: Review

References (210)

1. Halbwirth, H. The creation and physiological relevance of divergent hydroxylation patterns in the flavonoid pathway Int. J. Mol. Sci. 2010, 11, 595-621
2. Kris-Etherton, P. M.; Hecker, K. D.; Bonanome, A.; Coval, S. M.; Binkoski, A. E.; Hilpert, K. F.; Griel, A. E.; Etherton, T. D. Bioactive compounds in foods: Their role in the prevention of cardiovascular disease and cancer Am. J. Med. 2002, 113, 71-88
3. Naczk, M.; Shahidi, F. Extraction and analysis of phenolics in food J. Chromatogr. A 2004, 1054, 95-111
4. Panickar, K. S.; Anderson, R. A. Role of dietary polyphenols in attenuating brain edema and cell swelling in cerebral ischemia Recent Pat. CNS Drug Discov. 2010, 5, 99-108
5. Cheynier, V. Polyphenols in foods are more complex than often thought J. Clin. Nutr. 2005, 81, 223-229
6. Aziz, M. H.; Kumar, R.; Ahmad, N. Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (review) Int. J. Oncol. 2003, 23, 17-28
7. Beecher, G. R. Overview of dietary flavonoids: nomenclature, occurrence and intake J. Nutr. 2003, 133, 3248-3254
8. Wilska-Jeszka, J.; PodseÌ̈dek, A. Bioflawonoidy jako naturalne antyoksydanty (Bioflavonoids as natural antioxidants) Wiad. Chem. 2001, 55, 987-1003
9. Kuhnert, N. Unraveling the structure of the black tea thearubigins Arch. Biochem. Biophys. 2010, 501, 37-51
10. Andreotti, C.; Ravaglia, D.; Ragaini, A. Phenolic compounds in peach (Prunus persica) cultivars at harvest and during fruit maturation Ann. Appl. Biol. 2008, 153, 11-23
11. Bouaziz, M.; Jemai, H.; Khabou, W.; Sayadi, S. Oil content, phenolic profiling and antioxidant potential of Tunisian olive drupes J. Sci. Food Agric. 2010, 90, 1750-1758
12. Chuah, A. M.; Lee, Y. C.; Yamaguchi, T.; Takamura, H.; Yin, L. J.; Matoba, T. Effect of cooking on the antioxidant properties of colored peppers Food Chem. 2008, 111, 20-28
13. Roy, M. K.; Juneja, L. R.; Isobe, S.; Tsushida, T. Steam processed broccoli (Brassica oleracea) has higher antioxidant activity in chemical and cellular assay systems Food Chem. 2009, 114, 263-269
14. D'Archivio, M.; Filesi, C.; Vari, R.; Scazzocchio, B.; Masella, R. Bioavailability of the polyphenols: Status and controversies Int. J. Mol. Sci. 2010, 11, 1321-1342
15. Cerda, B.; Espin, J. C.; Parra, S.; Martinez, P.; Tomas-Barberan, F. A. The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans Eur. J. Nutr. 2004, 43, 205-220
16. Gonzalez-Sarrias, A.; Espin, J. C.; Tomas-Barberan, F. A.; Garcia-Conesa, M. T. Gene expression, cell cycle arrest, and MAPK signalling regulation in Caco-2 cells exposed to ellagic acid and its metabolites, urolithins Mol. Nutr. Food Res. 2009, 53, 686-698
17. Larrosa, M.; Tomas-Barberan, F. A.; Espin, J. C. The dietary hydrolysable tannin punicalagin releases ellagic acid that induces apoptosis in human colon adenocarcinoma Caco-2 cells by using the mitochondrial pathway J. Nutr. Biochem. 2006, 17, 611-625
18. Musiał, W.; Kubis, A. Biodegradable polymers for colon-specific drug delivery Polim. Med. 2005, 35, 51-61
19. Di Pierro, F.; Menghi, A. B.; Barreca, A.; Lucarelli, M.; Calandrelli, A. Greenselect phytosome as an adjunct to a low-calorie diet for treatment of obesity: A clinical trial Alternative Med. Rev. 2009, 14, 154-160
20. El-Samaligy, M. S.; Afifi, N. N.; Mahmoud, E. A. Increasing bioavailability of silymarin using a buccal liposomal delivery system: Preparation and experimental design investigation Int. J. Pharm. 2006, 308, 140-148
21. Yan-yu, X.; Yun-mei, S.; Zhi-peng, C.; Qi-neng, P. Preparation of silymarin proliposome: A new way to increase oral bioavailability of silymarin in beagle dogs Int. J. Pharm. 2006, 319, 162-168
22. Wu, H.; Lu, C.; Zhou, A.; Min, Z.; Zhang, Y. Enhanced oral bioavailability of puerarin using microemulsion vehicle Drug Dev. Ind. Pharm. 2009, 35, 138-144
23. Huang, Q.; Yu, H.; Ru, Q. Bioavailability and delivery of nutraceuticals using nanotechnology J. Food Sci. 2010, 75, R50-R57
24. Onoue, S.; Ochi, M.; Yamada, S. Development of (-)-epigallocatechin-3- gallate (EGCG)-loaded enteric microparticles with intestinal mucoadhesive property Int. J. Pharm. 2011, 410, 111-113
25. Shaikh, J.; Ankola, D. D.; Beniwal, V.; Singh, D.; Kumar, M. N. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer Eur. J. Pharm. Sci. 2009, 37, 223-230
26. Shoba, G.; Joy, D.; Joseph, T.; Majeed, M.; Rajendran, R.; Srinivas, P. S. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers Planta Med. 1998, 64, 353-356
27. Li, H.; Zhao, X.; Ma, Y.; Zhai, G.; Li, L.; Lou, H. Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles J. Controlled Release 2009, 133, 238-244
28. Lee, S. H.; Kim, Y. H.; Yu, H. J.; Cho, N. S.; Kim, T. H.; Kim, D. C.; Chung, C. B.; Hwang, Y. I.; Kim, K. H. Enhanced bioavailability of soy isoflavones by complexation with β-cyclodextrin in rats Biosci. Biotechnol. Biochem. 2007, 71, 2927-2933
29. Smith, A. J.; Kavuru, P.; Wojtas, L.; Zaworotko, M. J.; Shytle, R. D. Cocrystals of quercetin with improved solubility and oral bioavailability Mol. Pharm. 2011, 8, 1867-1876
30. Bandyopadhyay, P.; Ghosh, A. K.; Ghosh, C. Recent developments on polyphenol-protein interactions: Effects on tea and coffee taste, antioxidant properties, and the digestive system Food Funct. 2012, 3, 592-605
31. Spencer, J. P. Metabolism of tea flavanoids in gastrointestinal tract J. Nutr. 2003, 133, 3255S-3261S
32. Cai, K.; Bennick, A. Effect of salivary proteins on the transport of tannin and quercetin across intestinal epithelial cells in culture Biochem. Pharmacol. 2006, 72, 974-980
33. Tagliazucchi, D.; Verzelloni, E.; Bertolini, D.; Conte, A. In vitro bio-accessibility and antioxidant activity of grape polyphenols Food Chem. 2010, 120, 599-606
34. Boyer, J.; Brown, D.; Liu, R. H. In vitro digestion and lactase treatment influence uptake of quercetin and quercetin glucoside by the Caco-2 cell monolayer Nutr. J. 2005, 4, 1
35. Record, I. R.; Lane, J. M. Simulated intestinal digestion of green and black teas Food Chem. 2001, 73, 481-486
36. Rios, L. Y.; Bennett, R. N.; Lazarus, S. A.; Rémésy, C.; Scalbert, A.; Williamson, G. Cocoa procyanidins are stable during gastric transit in humans Am. J. Clin. Nutr. 2002, 76, 1106-1110
37. Stoupi, S.; Williamson, G.; Viton, F.; Barron, D.; King, L. J.; Brown, J. E.; Clifford, M. N. In vivo bioavailability, absorption, excretion, and pharmacokinetics of [14C]procyanidin B2 in male rats Drug Metab. Dispos. 2010, 38, 287-291
38. Spencer, J. P.; Chaudry, F.; Pannala, A. S.; Srai, S. K.; Debnam, E.; Rice-Evans, C. Decomposition of coca procyanidins in the gastric milieu Biochem. Biophys. Res. Commun. 2000, 272, 236-241
39. Passamonti, S.; Vrhovsek, U.; Vanzo, A.; Mattivi, F. The stomach as a site for anthocyanins absorption from food FEBS Lett. 2003, 544, 210-213
40. Župerl, Š.; Fornasaro, S.; Novič, M.; Passamonti, S. Experimental determination and prediction of bilitranslocase transport activity Anal. Chim. Acta 2011, 705, 322-333
41. Passamonti, S.; Vanzo, A.; Vrhovsek, U.; Terdoslavich, M.; Cocolo, A.; Decorti, G.; Mattivi, F. Hepatic uptake of grape anthocyanins and the role of bilitranslocase Food Res. Int. 2005, 38, 953-960
42. Karawajczyk, A.; Drgan, V.; Medic, N.; Oboh, G.; Passamonti, S.; Novic, M. Properties of flavonoids influencing the binding to bilitranslocase investigated by neural network modelling Biochem. Pharmacol. 2007, 73, 308-320
43. Farrell, T. L.; Gomez-Juaristi, M.; Poquet, L.; Redeuil, K.; Nagy, K.; Renouf, M.; Williamson, G. Absorption of dimethoxycinnamic acid derivatives in vitro and pharmacokinetic profile in human plasma following coffee consumption Mol. Nutr. Food Res. 2012, 56, 1413-1423
44. Lafay, S.; Gil-Izquierdo, A.; Manach, C.; Morand, C.; Besson, C.; Scalbert, A. Chlorogenic acid is absorbed in its intact form in the stomach of rats J. Nutr. 2006, 136, 1192-1197
45. Konishi, Y.; Zhao, Z.; Shimizu, M. Phenolic acids are absorbed from the rat stomach with different absorption rates J. Agric. Food Chem. 2006, 54, 7539-7543
46. Kay, C. D. Aspects of anthocyanin absorption, metabolism, and pharmacokinetics in humans Nutr. Res. Rev. 2006, 19, 137-146
47. Kuhnle, G.; Spencer, J. P.; Schroeter, H.; Shenoy, B.; Debnam, E. S.; Srai, S. K.; Rice-Evans, C.; Hahn, U. Epicatechin and catechin are O-methylated and glucuronidated in the small intestine Biochem. Biophys. Res. Commun. 2000, 277, 507-512
48. Weinert, C. H.; Wiese, S.; Rawel, H. M.; Esatbeyoglu, T.; Winterhalter, P.; Homann, T.; Kulling, S. E. Methylation of catechins and procyanidins by rat and human catechol-O-methyltransferase: metabolite profiling and molecular modeling studies Drug Metab. Dispos. 2012, 40, 353-359
49. Vaidyanathan, J. B.; Walle, T. Glucuronidation and sulfation of the tea flavonoid (-)-epicatechin by the human and rat enzymes Drug Metab. Dispos. 2002, 30, 897-903
50. Selma, M. V.; Espín, J. C.; Tomás-Barberán, F. A. Interaction between phenolics and gut microbiota: Role in human health J. Agric. Food Chem. 2009, 57, 6485-6501
51. Hodek, P.; Trefil, P.; Stiborová, M. Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450 Chem. Biol. Interact. 2002, 139, 1-21
52. Otake, Y.; Hsieh, F.; Walle, T. Glucuronidation versus oxidation of the flavonoid galangin by human liver microsomes and hepatocytes Drug Metab. Dispos. 2002, 30, 576-581
53. Aura, A. M. Microbial metabolism of dietary phenolic compounds in the colon Phytochem. Rev. 2008, 7, 407-429
54. Roowi, S.; Stalmach, A.; Mullen, W.; Lean, M. E.; Edwards, C. A.; Crozier, A. Green tea flavan-3-ols: Colonic degradation and urinary excretion of catabolites by humans J. Agric. Food Chem. 2010, 58, 1296-1304
55. Urpi-Sarda, M.; Monagas, M.; Khan, N.; Llorach, R.; Lamuela- Raventós, R. M.; Jáuregui, O.; Estruch, R.; Izquierdo-Pulido, M.; Andrés-Lacueva, C. Targeted metabolic profiling of phenolics in urine and plasma after regular consumption of cocoa by liquid chromatography-tandem mass spectrometry J. Chromatogr. A. 2009, 1216, 7258-7267
56. Touriño, S.; Fuguet, E.; Vinardell, M. P.; Cascante, M.; Torres, J. L. Phenolic metabolites of grape antioxidant dietary fiber in rat urine J. Agric. Food Chem. 2009, 57, 11418-11426
57. Donovan, J. L.; Crespy, V.; Manach, C.; Morand, C.; Besson, C.; Scalbert, A.; Rémésy, C. Catechin is metabolized by both the small intestine and liver of rats J. Nutr. 2001, 131, 1753-1757
58. Xing, J.; Chen, X.; Zhong, D. Absorption and enterohepatic circulation of baicalin in rats Life Sci. 2005, 78, 140-146
59. Manach, C.; Scalbert, A.; Morand, C.; Rémésy, C.; Jiménez, L. Polyphenols: Food sources and bioavailability Am. J. Clin. Nutr. 2004, 79, 727-747
60. Serra, A.; Rubió, L.; Borràs, X.; Macià, A.; Romero, M. P.; Motilva, M. J. Distribution of olive oil phenolic compounds in rat tissues after administration of a phenolic extract from olive cake Mol. Nutr. Food Res. 2012, 56, 486-496
61. Zhang, Y. J.; Wu, L.; Zhang, Q. L.; Li, J.; Yin, F. X.; Yuan, Y. Pharmacokinetics of phenolic compounds of Danshen extract in rat blood and brain by microdialysis sampling J. Ethnopharmacol. 2011, 136, 129-136
62. Garateix, A.; Salceda, E.; Menéndez, R.; Regalado, E. L.; López, O.; García, T.; Morales, R. A.; Laguna, A.; Thomas, O. P.; Soto, E. Antinociception produced by Thalassia testudinum extract BM-21 is mediated by the inhibition of acid sensing ionic channels by the phenolic compound thalassiolin B Mol. Pain 2011, 7, 10
63. Henning, S. M.; Aronson, W.; Niu, Y.; Conde, F.; Lee, N. H.; Seeram, N. P.; Lee, R. P.; Lu, J.; Harris, D. M.; Moro, A.; Hong, J.; Pak-Shan, L.; Barnard, R. J.; Ziaee, H. G.; Csathy, G.; Go, V. L.; Wang, H.; Heber, D. Tea polyphenols and theaflavins are present in prostate tissue of humans and mice after green and black tea consumption J. Nutr. 2006, 136, 1839-1843
64. Bolca, S.; Urpi-Sarda, M.; Blondeel, P.; Roche, N.; Vanhaecke, L.; Possemiers, S.; Al-Maharik, N.; Botting, N.; De Keukeleire, D.; Bracke, M.; Heyerick, A.; Manach, C.; Depypere, H. Disposition of soy isoflavones in normal human breast tissue Am. J. Clin. Nutr. 2010, 91, 976-984
65. Calani, L.; Dall'Asta, M.; Derlindati, E.; Scazzina, F.; Bruni, R.; Del Rio, D. Colonic metabolism of polyphenols from coffee, green tea, and hazelnut skins J. Clin. Gastroenterol. 2012, 46 (Suppl) S95-S99
66. Delmas, D.; Lin, H. Y. Role of membrane dynamics processes and exogenous molecules in cellular resveratrol uptake: Consequences in bioavailability and activities Mol. Nutr. Food Res. 2011, 55, 1142-1153
67. Alvarez, A. I.; Real, R.; Pérez, M.; Mendoza, G.; Prieto, J. G.; Merino, G. Modulation of the activity of ABC transporters (P-glycoprotein, MRP2, BCRP) by flavonoids and drug response J. Pharm. Sci. 2010, 99, 598-617
68. Brand, W.; Schutte, M. E.; Williamson, G.; van Zanden, J. J.; Cnubben, N. H.; Groten, J. P.; van Bladeren, P. J.; Rietjens, I. M. Flavonoid-mediated inhibition of intestinal ABC transporters may affect the oral bioavailability of drugs, food-borne toxic compounds, and bioactive ingredients Biomed. Pharmacother. 2006, 60, 508-519
69. van de Wetering, K.; Burkon, A.; Feddema, W.; Bot, A.; de Jonge, H.; Somoza, V.; Borst, P. Intestinal breast cancer resistance protein (BCRP)/Bcrp1 and multidrug resistance protein 3 (MRP3)/Mrp3 are involved in the pharmacokinetics of resveratrol Mol. Pharmacol. 2009, 75, 876-885
70. Kaldas, M. I.; Walle, U. K.; Walle, T. Resveratrol transport and metabolism by human intestinal Caco-2 cells J. Pharm. Pharmacol. 2003, 55, 307-312
71. Nait Chabane, M.; Al Ahmad, A.; Peluso, J.; Muller, C. D.; Ubeaud, G. Quercetin and naringenin transport across human intestinal Caco-2 cells J. Pharm. Pharmacol. 2009, 61, 1473-1483
72. Williamson, G.; Aeberli, I.; Miguet, L.; Zhang, Z.; Sanchez, M. B.; Crespy, V.; Barron, D.; Needs, P.; Kroon, P. A.; Glavinas, H.; Krajcsi, P.; Grigorov, M. Interaction of positional isomers of quercetin glucuronides with the transporter ABCC2 (cMOAT, MRP2) Drug Metab. Dispos. 2007, 35, 1262-1268
73. Wolffram, S.; Blöck, M.; Ader, P. Quercetin-3-glucoside is transported by the glucose carrier SGLT1 across the brush border membrane of rat small intestine J. Nutr. 2002, 132, 630-635
74. Strobel, P.; Allard, C.; Perez-Acle, T.; Calderon, R.; Aldunate, R.; Leighton, F. Myricetin, quercetin, and catechin-gallate inhibit glucose uptake in isolated rat adipocytes Biochem. J. 2005, 386, 471-478
75. Cunningham, P.; Afzal-Ahmed, I.; Naftalin, R. J. Docking studies show that d -glucose and quercetin slide through the transporter GLUT1 J. Biol. Chem. 2006, 281, 5797-5803
76. Morris, M. E.; Zhang, S. Flavonoid-drug interactions: Effects of flavonoids on ABC transporters Life Sci. 2006, 78, 2116-2130
77. Zhang, Y.; Gordon, G. B. A strategy for cancer prevention: Stimulation of the Nrf2-ARE signaling pathway Mol. Cancer Ther. 2004, 3, 885-893
78. Ciolino, H. P.; Yeh, G. C. The flavonoid galangin is an inhibitor of CYP1A1 activity and an agonist/antagonist of the aryl hydrocarbon receptor Br. J. Cancer. 1999, 79, 1340-1346
79. Ciolino, H. P.; Wang, T. T.; Yeh, G. C. Diosmin and diosmetin are agonists of the aryl hydrocarbon receptor that differentially affect cytochrome P450 1A1 activity Cancer Res. 1998, 58, 2754-2760
80. Canivenc-Lavier, M. C.; Bentejac, M.; Miller, M. L.; Leclerc, J.; Siess, M. H.; Latruffe, N.; Suschetet, M. Differential effects of nonhydroxylated flavonoids as inducers of cytochrome P450 1A and 2B isozymes in rat liver Toxicol. Appl. Pharmacol. 1996, 136, 348-353
81. Vaquero, M. P.; Sánchez Muniz, F. J.; Jiménez Redondo, S.; Prats Oliván, P.; Higueras, F. J.; Bastida, S. Major diet-drug interactions affecting the kinetic characteristics and hypolipidaemic properties of statins Nutr. Hosp. 2010, 25, 193-206
82. Dahan, A.; Altman, H. Food-drug interaction: Grapefruit juice augments drug bioavailability-mechanism, extent, and relevance Eur. J. Clin. Nutr. 2004, 58, 1-9
83. Svehlíková, V.; Wang, S.; Jakubíková, J.; Williamson, G.; Mithen, R.; Bao, Y. Interactions between sulforaphane and apigenin in the induction of UGT1A1 and GSTA1 in CaCo-2 cells Carcinogenesis 2004, 25, 1629-1637
84. Chen, Y.; Huang, C.; Zhou, T.; Chen, G. Genistein induction of human sulfotransferases in HepG2 and Caco-2 cells Basic Clin. Pharmacol. Toxicol. 2008, 103, 553-559
85. Chen, Y.; Huang, C.; Zhou, T.; Zhang, S.; Chen, G. Biochanin A induction of sulfotransferases in rats J. Biochem. Mol. Toxicol. 2010, 24, 102-114
86. Brand, W.; Schutte, M. E.; Williamson, G.; van Zanden, J. J.; Cnubben, N. H.; Groten, J. P.; van Bladeren, P. J.; Rietjens, I. M. Flavonoid-mediated inhibition of intestinal ABC transporters may affect the oral bioavailability of drugs, food-borne toxic compounds and bioactive ingredients Biomed. Pharmacother. 2006, 60, 508-519
87. de Castro, W. V.; Mertens-Talcott, S.; Derendorf, H.; Butterweck, V. Grapefruit juice-drug interactions: Grapefruit juice and its components inhibit P-glycoprotein (ABCB1) mediated transport of talinolol in Caco-2 cells J. Pharm. Sci. 2007, 96, 2808-2817
88. Bailey, D. G.; Dresser, G. K.; Leake, B. F.; Kim, R. B. Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide1A2 (OATP1A2) in grapefruit juice Clin. Pharmacol. Ther. 2007, 81, 495-502
89. Kidd, P. M. Bioavailability and activity of phytosome complexes from botanical polyphenols: The silymarin, curcumin, green tea, and grape seed extracts Altern. Med. Rev. 2009, 14, 226-246
90. Scalbert, A.; Williamson, G. Dietary intake and bioavailability of polyphenols J. Nutr. 2000, 130, 2073-2085
91. Musiał, W.; Kubis, A. Biodegradable polymers for colon-specific drug delivery Polim. Med. 2005, 35, 51-61
92. Ajazuddin, S. Applications of novel drug delivery system for herbal formulations Fitoterapia 2010, 81, 680-689
93. Ansari, K. A.; Vavia, P. R.; Trotta, F.; Cavalli, R. Cyclodextrin-based nanosponges for delivery of resveratrol: In vitro characterization, stability, cytotoxicity, and permeation study AAPS PharmSciTech 2011, 12, 279-286
94. Borghetti, G. S.; Pinto, A. P.; Lula, I. S.; Sinisterra, R. D.; Teixeira, H. F.; Bassani, V. L. Daidzein/cyclodextrin/hydrophilic polymer ternary systems Drug Dev. Ind. Pharm. 2011, 37, 886-893
95. Zhao, C.; Wang, Y.; Su, Y.; Zhang, H.; Ding, L.; Yan, X.; Zhao, D.; Shao, N.; Ye, X.; Cheng, Y. Inclusion complexes of isoflavones with two commercially available dendrimers: Solubility, stability, structures, release behaviors, cytotoxicity, and anti-oxidant activities Int. J. Pharm. 2011, 421, 301-309
96. Yao, C.; Wang, W.; Zhou, X.; Qu, T.; Mu, H.; Liang, R.; Wang, A.; Sun, K. Effects of poly(amidoamine) dendrimers on ocular absorption of puerarin using microdialysis J. Ocul. Pharmacol. Ther. 2011, 27, 565-569
97. Anand, P.; Kunnumakkara, A. B.; Newman, R. A.; Aggarwal, B. B. Bioavailability of curcumin: problems and promises Mol. Pharmaceutics 2007, 4, 807-118
98. Gagliardi, S.; Ghirmai, S.; Abel, K. J.; Lanier, M.; Gardai, S. J.; Lee, C.; Cashman, J. R. Evaluation in vitro of synthetic curcumins as agents promoting monocytic gene expression related to β-amyloid clearance Chem. Res. Toxicol. 2012, 25, 101-112
99. Lambert, J. D.; Sang, S.; Hong, J.; Kwon, S. J.; Lee, M. J.; Ho, C. T.; Yang, C. S. Peracetylation as a means of enhancing in vitro bioactivity and bioavailability of epigallocatechin-3-gallate Drug Metab. Dispos. 2006, 34, 2111-2116
100. Biasutto, L.; Marotta, E.; De Marchi, U.; Zoratti, M.; Paradisi, C. Ester-based precursors to increase the bioavailability of quercetin J. Med. Chem. 2007, 50, 241-253
101. Walle, T. Methylation of dietary flavones greatly improves their hepatic metabolic stability and intestinal absorption Mol. Pharmaceutics 2007, 4, 826-832
102. Lambert, J. D.; Hong, J.; Kim, D. H.; Mishin, V. M.; Yang, C. S. Piperine enhances the bioavailability of the tea polyphenol (-)-epigallocatechin-3- gallate in mice J. Nutr. 2004, 134, 1948-1952
103. Olivella, M. S.; Lhez, L.; Pappano, N. B.; Debattista, N. B. Effects of dimethylformamide and l -menthol permeation enhancers on transdermal delivery of quercetin Pharm. Dev. Technol. 2007, 12, 481-484
104. Felice, F.; Zambito, Y.; Di Colo, G.; D'Onofrio, C.; Fausto, C.; Balbarini, A.; Di Stefano, R. Red grape skin and seeds polyphenols: Evidence of their protective effects on endothelial progenitor cells and improvement of their intestinal absorption Eur. J. Pharm. Biopharm. 2012, 80, 176-184
105. Garg, R.; Gupta, G. D. Preparation and evaluation of gastroretentive floating tablets of Silymarin Chem. Pharm. Bull (Tokyo) 2009, 57, 545-549
106. Rosenzweig, O.; Lavy, E.; Gati, I.; Kohen, R.; Friedman, M. Development and in vitro characterization of floating sustained-release drug delivery systems of polyphenols Drug Deliv. 2013, 20, 180-189
107. Savio, D.; Harrasser, P. C.; Basso, G. Softgel capsule technology as an enhancer device for the absorption of natural principles in humans. A bioavailability cross-over randomised study on silybin Arzneimittelforschung 1998, 48, 1104-1106
108. Cheng, S. Y.; Shaw, N. S.; Tsai, K. S.; Chen, C. Y. The hypoglycemic effects of soy isoflavones on postmenopausal women J. Women's Health (Larchmt) 2004, 13, 1080-1086
109. Cao, P.; Vadhanam, M. V.; Spencer, W. A.; Cai, J.; Gupta, R. C. Sustained systemic delivery of green tea polyphenols by polymeric implants significantly diminishes benzo[a]pyrene-induced DNA adducts Chem. Res. Toxicol. 2011, 24, 877-886
110. Aqil, F.; Vadhanam, M. V.; Gupta, R. C. Enhanced activity of punicalagin delivered via polymeric implants against benzo[a]pyrene-induced DNA adducts Mutat. Res. 2012, 743, 59-66
111. Singh, A. T.; Ghosh, M.; Forte, T. M.; Ryan, R. O.; Gordon, L. I. Curcumin nanodisk-induced apoptosis in mantle cell lymphoma Leuk. Lymphoma. 2011, 52, 1537-1543
112. Merrell, J. G.; McLaughlin, S. W.; Tie, L.; Laurencin, C. T.; Chen, A. F.; Nair, L. S. Curcumin-loaded poly(epsilon-caprolactone) nanofibres: Diabetic wound dressing with anti-oxidant and anti-inflammatory properties Clin. Exp. Pharmacol. Physiol. 2009, 36, 1149-1156
113. Zhang, J.; Lv, H.; Jiang, K.; Gao, Y. Enhanced bioavailability after oral and pulmonary administration of baicalein nanocrystal Int. J. Pharm. 2011, 420, 180-188
114. Smith, A. J.; Kavuru, P.; Arora, K. K.; Kesani, S.; Tan, J.; Zaworotko, M. J.; Shytle, R. D. Crystal engineering of green tea epigallocatechin-3-gallate (EGCg) cocrystals and pharmacokinetic modulation in rats Mol. Pharmacol. 2013, 10, 2948-2961
115. Pietta, P.; Simonetti, P.; Gardana, C.; Brusamolino, A.; Morazzoni, P.; Bombardelli, E. Relationship between rate and extent of catechin absorption and plasma antioxidant status Biochem. Mol. Biol. Int. 1998, 46, 895-903
116. Hoh, C.; Boocock, D.; Marczylo, T.; Singh, R.; Berry, D. P.; Dennison, A. R.; Hemingway, D.; Miller, A.; West, K.; Euden, S.; Garcea, G.; Farmer, P. B.; Steward, W. P.; Gescher, A. J. Pilot study of oral silibinin, a putative chemopreventive agent, in colorectal cancer patients: Silibinin levels in plasma, colorectum, and liver and their pharmacodynamic consequences Clin. Cancer Res. 2006, 12, 2944-2950
117. Flaig, T. W.; Gustafson, D. L.; Su, L. J.; Zirrolli, J. A.; Crighton, F.; Harrison, G. S.; Pierson, A. S.; Agarwal, R.; Glodé, L. M. A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients Invest. New Drugs 2007, 25, 139-146
118. Flaig, T. W.; Glodé, M.; Gustafson, D.; van Bokhoven, A.; Tao, Y.; Wilson, S.; Su, L. J.; Li, Y.; Harrison, G.; Agarwal, R.; Crawford, E. D.; Lucia, M. S.; Pollak, M. A study of high-dose oral silybin-phytosome followed by prostatectomy in patients with localized prostate cancer Prostate 2010, 70, 848-855
119. Belcaro, G.; Cesarone, M. R.; Dugall, M.; Pellegrini, L.; Ledda, A.; Grossi, M. G.; Togni, S.; Appendino, G. Efficacy and safety of Meriva, a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients Alternative Med. Rev. 2010, 15, 337-344
120. Ledda, A.; Belcaro, G.; Dugall, M.; Luzzi, R.; Scoccianti, M.; Togni, S.; Appendino, G.; Ciammaichella, G. Meriva, a lecithinized curcumin delivery system, in the control of benign prostatic hyperplasia: A pilot, product evaluation registry study Panminerva Med. 2012, 54, 17-22
121. Steigerwalt, R.; Nebbioso, M.; Appendino, G.; Belcaro, G.; Ciammaichella, G.; Cornelli, U.; Luzzi, R.; Togni, S.; Dugall, M.; Cesarone, M. R.; Ippolito, E.; Errichi, B. M.; Ledda, A.; Hosoi, M.; Corsi, M. Meriva, a lecithinized curcumin delivery system, in diabetic microangiopathy and retinopathy Panminerva Med. 2012, 54, 11-16
122. Di Pierro, F.; Rapacioli, G.; Di Maio, E. A.; Appendino, G.; Franceschi, F.; Togni, S. Comparative evaluation of the pain-relieving properties of a lecithinized formulation of curcumin (Meriva), nimesulide, and acetaminophen J. Pain Res. 2013, 6, 201-205
123. Loguercio, C.; Andreone, P.; Brisc, C.; Brisc, M. C.; Bugianesi, E.; Chiaramonte, M.; Cursaro, C.; Danila, M.; de Sio, I.; Floreani, A.; Freni, M. A.; Grieco, A.; Groppo, M.; Lazzari, R.; Lobello, S.; Lorefice, E.; Margotti, M.; Miele, L.; Milani, S.; Okolicsanyi, L.; Palasciano, G.; Portincasa, P.; Saltarelli, P.; Smedile, A.; Somalvico, F.; Spadaro, A.; Sporea, I.; Sorrentino, P.; Vecchione, R.; Tuccillo, C.; Del Vecchio Blanco, C.; Federico, A. Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: A randomized controlled trial Free Radic. Biol. Med. 2012, 52, 1658-1665
124. Zhang, J.; Tang, Q.; Xu, X.; Li, N. Development and evaluation of a novel phytosome-loaded chitosan microsphere system for curcumin delivery Int. J. Pharm. 2013, 448, 168-174
125. Maheshwari, H.; Agarwal, R.; Patil, C.; Katare, O. P. Preparation and pharmacological evaluation of silibinin liposomes Arzneimittelforschung 2003, 53, 420-427
126. El-Samaligy, M. S.; Afifi, N. N.; Mahmoud, E. A. Evaluation of hybrid liposomes-encapsulated silymarin regarding physical stability and in vivo performance Int. J. Pharm. 2006, 17, 121-129
127. Ambardekar, R. V.; Mahadik, K. R.; Paradkar, A. R.; Harsulkar, A. M. Enhancement of hepatoprotective efficacy of propolis by fabrication of liposomes, as a platform nano-formulation for multi-component natural medicine Curr. Drug Deliv. 2012, 9, 477-4786
128. Park, S. N.; Lee, M. H.; Kim, S. J.; Yu, E. R. Preparation of quercetin and rutin-loaded ceramide liposomes and drug-releasing effect in liposome-in-hydrogel complex system Biochem. Biophys. Res. Commun. 2013, 435, 361-366
129. Chu, C.; Tong, S. S.; Xu, Y.; Wang, L.; Fu, M.; Ge, Y. R.; Yu, J. N.; Xu, X. M. Proliposomes for oral delivery of dehydrosilymarin: preparation and evaluation in vitro and in vivo Acta Pharmacol. Sin. 2011, 32, 973-980
130. Gou, M.; Men, K.; Shi, H.; Xiang, M.; Zhang, J.; Song, J.; Long, J.; Wan, Y.; Luo, F.; Zhao, X.; Qian, Z. Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo Nanoscale 2011, 3, 1558-1567
131. Song, Z.; Feng, R.; Sun, M.; Guo, C.; Gao, Y.; Li, L.; Zhai, G. Curcumin-loaded PLGA-PEG-PLGA triblock copolymeric micelles: Preparation, pharmacokinetics and distribution in vivo J. Colloid Interface Sci. 2011, 354, 116-123
132. Liu, L.; Sun, L.; Wu, Q.; Guo, W.; Li, L.; Chen, Y.; Li, Y.; Gong, C.; Qian, Z.; Wei, Y. Curcumin loaded polymeric micelles inhibit breast tumor growth and spontaneous pulmonary metastasis Int. J. Pharm. 2013, 443, 175-182
133. Gong, C.; Deng, S.; Wu, Q.; Xiang, M.; Wei, X.; Li, L.; Gao, X.; Wang, B.; Sun, L.; Chen, Y.; Li, Y.; Liu, L.; Qian, Z.; Wei, Y. Improving antiangiogenesis and anti-tumor activity of curcumin by biodegradable polymeric micelles Biomaterials 2013, 34, 1413-1432
134. Gong, C.; Wu, Q.; Wang, Y.; Zhang, D.; Luo, F.; Zhao, X.; Wei, Y.; Qian, Z. A biodegradable hydrogel system containing curcumin encapsulated in micelles for cutaneous wound healing Biomaterials 2013, 34, 6377-6387
135. Bergamante, V.; Ceschel, G. C.; Marazzita, S.; Ronchi, C.; Fini, A. Effect of vehicles on topical application of aloe vera and arnica montana components Drug Deliv. 2007, 14, 427-432
136. Yao, J.; Zhou, J. P.; Ping, Q. N.; Lu, Y.; Chen, L. Distribution of nobiletin chitosan-based microemulsions in brain following i.v. injection in mice Int. J. Pharm. 2008, 352, 256-262
137. Yue, P. F.; Hai-Long Yuan, H. L.; Zhu, W. F.; Cong, L. B.; Xie, H.; Liu, Z. G.; Wang, L. J.; Xiao, X. H. The study to reduce the hemolysis side effect of puerarin by a submicron emulsion delivery system Biol. Pharm. Bull. 2008, 31, 45-50
138. Kitagawa, S.; Tanaka, Y.; Tanaka, M.; Endo, K.; Yoshii, A. Enhanced skin delivery of quercetin by microemulsion J. Pharm. Pharmacol. 2009, 61, 855-860
139. Rogerio, A. P.; Dora, C. L.; Andrade, E. L.; Chaves, J. S.; Silva, L. F.; Lemos-Senna, E.; Calixto, J. B. Anti-inflammatory effect of quercetin-loaded microemulsion in the airways allergic inflammatory model in mice Pharmacol. Res. 2010, 61, 288-297
140. Yen, F. L.; Wu, T. H.; Lin, L. T.; Cham, T. M.; Lin, C. C. Nanoparticles formulation of Cuscuta chinensis prevents acetaminophen-induced hepatotoxicity in rats Food Chem. Toxicol. 2008, 46, 1771-1777
141. Wang, Y.; Wang, L.; Liu, Z.; Zhang, D.; Zhang, Q. In vivo evaluation of silybin nanosuspensions targeting liver J. Biomed. Nanotechnol. 2012, 8, 760-769
142. Cui, S.; Zhao, C.; Tang, X.; Chen, D.; He, Z. Study on the bioavailability of puerarin from Pueraria lobata isoflavone self- microemulsifying drug-delivery systems and tablets in rabbits by liquid chromatography-mass spectrometry Biomed. Chromatogr. 2005, 19, 375-378
143. Quan, D. Q.; Xu, G. X.; Wu, X. G. Studies on preparation and absolute bioavailability of a self-emulsifying system containing puerarin Chem. Pharm. Bull. (Tokyo) 2007, 55, 800-803
144. Woo, J. S.; Kim, T. S.; Park, J. H.; Chi, S. C. Formulation and biopharmaceutical evaluation of silymarin using SMEDDS Arch. Pharm. Res. 2007, 30, 82-89
145. Shen, Q.; Li, X.; Yuan, D.; Jia, W. Enhanced oral bioavailability of daidzein by self-microemulsifying drug delivery system Chem. Pharm. Bull. (Tokyo) 2010, 58, 639-643
146. Li, W.; Yi, S.; Wang, Z.; Chen, S.; Xin, S.; Xie, J.; Zhao, C. Self-nanoemulsifying drug delivery system of persimmon leaf extract: Optimization and bioavailability studies Int. J. Pharm. 2011, 420, 161-171
147. Zhang, J.; Peng, Q.; Shi, S.; Zhang, Q.; Sun, X.; Gong, T.; Zhang, Z. Preparation, characterization, and in vivo evaluation of a self-nanoemulsifying drug delivery system (SNEDDS) loaded with morin-phospholipid complex Int. J. Nanomed. 2011, 6, 3405-3414
148. Liu, W.; Tian, R.; Hu, W.; Jia, Y.; Jiang, H.; Zhang, J.; Zhang, L. Preparation and evaluation of self-microemulsifying drug delivery system of baicalein Fitoterapia 2012, 83, 1532-1539
149. Kanaze, F. I.; Bounartzi, M. I.; Georgarakis, M.; Niopas, I. Pharmacokinetics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects Eur. J. Clin. Nutr. 2007, 61, 472-477
150. Han, H. K.; Lee, B. J.; Lee, H. K. Enhanced dissolution and bioavailability of biochanin A via the preparation of solid dispersion: In vitro and in vivo evaluation Int. J. Pharm. 2011, 415, 89-94
151. Han, H. K.; Lee, H. K. Improved effectiveness of biochanin A as a P-gp inhibitor in solid dispersion Pharmazie 2011, 66, 710-715
152. Jia, L.; Zhang, D.; Li, Z.; Duan, C.; Wang, Y.; Feng, F.; Wang, F.; Liu, Y.; Zhang, Q. Nanostructured lipid carriers for parenteral delivery of silybin: Biodistribution and pharmacokinetic studies Colloids Surf. B: Biointerfaces 2010, 80, 213-218
153. Chen-yu, G.; Chun-fen, Y.; Qi-lu, L.; Qi, T.; Yan-wei, X.; Wei-na, L.; Guang-xi, Z. Development of a quercetin-loaded nanostructured lipid carrier formulation for topical delivery Int. J. Pharm. 2012, 430, 292-298
154. Tsai, M. J.; Wu, P. C.; Huang, Y. B.; Chang, J. S.; Lin, C. L.; Tsai, Y. H.; Fang, J. Y. Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting Int. J. Pharm. 2012, 423, 461-470
155. Neves, A. R.; Lúcio, M.; Martins, S.; Lima, J. L.; Reis, S. Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability Int. J. Nanomed. 2013, 8, 177-187
156. Lyseng-Williamson, K. A.; Perry, C. M. Micronised purified flavonoid fraction: A review of its use in chronic venous insufficiency, venous ulcers, and haemorrhoids Drugs 2003, 63, 71-100
157. Takumi, H.; Nakamura, H.; Simizu, T.; Harada, R.; Kometani, T.; Nadamoto, T.; Mukai, R.; Murota, K.; Kawai, Y.; Terao, J. Bioavailability of orally administered water-dispersible hesperetin and its effect on peripheral vasodilatation in human subjects: Implication of endothelial functions of plasma conjugated metabolites Food Funct 2012, 3, 389-398
158. Chen, A. Z.; Li, Y.; Chau, F. T.; Lau, T. Y.; Hu, J. Y.; Zhao, Z.; Mok, D. K. Microencapsulation of puerarin nanoparticles by poly(l -lactide) in a supercritical CO(2) process Acta Biomater. 2009, 5, 2913-2919
159. Shahani, K.; Swaminathan, S. K.; Freeman, D.; Blum, A.; Ma, L.; Panyam, J. Injectable sustained release microparticles of curcumin: A new concept for cancer chemoprevention Cancer Res. 2010, 70, 4443-4452
160. Xie, X.; Tao, Q.; Zou, Y.; Zhang, F.; Guo, M.; Wang, Y.; Wang, H.; Zhou, Q.; Yu, S. PLGA nanoparticles improve the oral bioavailability of curcumin in rats: Characterizations and mechanisms J. Agric. Food Chem. 2011, 59, 9280-9289
161. Shutava, T. G.; Balkundi, S. S.; Lvov, Y. M. (-)-Epigallocatechin gallate/gelatin layer-by-layer assembled films and microcapsules J. Colloid Interface Sci. 2009, 330, 276-283
162. Shutava, T. G.; Balkundi, S. S.; Vangala, P.; Steffan, J. J.; Bigelow, R. L.; Cardelli, J. A.; O'Neal, D. P.; Lvov, Y. M. Layer-by-layer-coated gelatin nanoparticles as a vehicle for delivery of natural polyphenols ACS Nano 2009, 3, 1877-1885
163. Taylor, J.; Taylor, J. R.; Belton, P. S.; Minnaar, A. Kafirin microparticle encapsulation of catechin and sorghum condensed tannins J. Agric. Food Chem. 2009, 57, 7523-7528
164. Guazelli, C. F.; Fattori, V.; Colombo, B. B.; Georgetti, S. R.; Vicentini, F. T.; Casagrande, R.; Baracat, M. M.; Verri, W. A., Jr. Quercetin-loaded microcapsules ameliorate experimental colitis in mice by anti-inflammatory and antioxidant mechanisms J. Nat. Prod. 2013, 76, 200-208
165. Gavini, E.; Alamanni, M. C.; Cossu, M.; Giunchedi, P. Tabletted microspheres containing Cynara scolymus (var. Spinoso sardo) extract for the preparation of controlled release nutraceutical matrices J. Microencapsul. 2005, 22, 487-499
166. Ge, Y. B.; Chen, D. W.; Xie, L. P.; Zhang, R. Q. Optimized preparation of daidzein-loaded chitosan microspheres and in vivo evaluation after intramuscular injection in rats Int. J. Pharm. 2007, 338, 142-151
167. Natarajan, V.; Krithica, N.; Madhan, B.; Sehgal, P. K. Formulation and evaluation of quercetin polycaprolactone microspheres for the treatment of rheumatoid arthritis J. Pharm. Sci. 2011, 100, 195-205
168. Sasaki, H.; Sunagawa, Y.; Takahashi, K.; Imaizumi, A.; Fukuda, H.; Hashimoto, T.; Wada, H.; Katanasaka, Y.; Kakeya, H.; Fujita, M.; Hasegawa, K.; Morimoto, T. Innovative preparation of curcumin for improved oral bioavailability Biol. Pharm. Bull. 2011, 34, 660-665
169. Kanai, M.; Imaizumi, A.; Otsuka, Y.; Sasaki, H.; Hashiguchi, M.; Tsujiko, K.; Matsumoto, S.; Ishiguro, H.; Chiba, T. Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers Cancer Chemother. Pharmacol. 2012, 69, 65-70
170. Kanai, M.; Otsuka, Y.; Otsuka, K.; Sato, M.; Nishimura, T.; Mori, Y.; Kawaguchi, M.; Hatano, E.; Kodama, Y.; Matsumoto, S.; Murakami, Y.; Imaizumi, A.; Chiba, T.; Nishihira, J.; Shibata, H. A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin) in cancer patients Cancer Chemother. Pharmacol. 2013, 71, 1521-1530
171. Cao, X.; Fu, M.; Wang, L.; Liu, H.; Deng, W.; Qu, R.; Su, W.; Wei, Y.; Xu, X.; Yu, J. Oral bioavailability of silymarin formulated as a novel 3-day delivery system based on porous silica nanoparticles Acta Biomater. 2012, 8, 2104-2112
172. Cao, X.; Deng, W.; Fu, M.; Zhu, Y.; Liu, H.; Wang, L.; Zeng, J.; Wei, Y.; Xu, X.; Yu, J. Seventy-two-hour release formulation of the poorly soluble drug silybin based on porous silica nanoparticles: In vitro release kinetics and in vitro/in vivo correlations in beagle dogs Eur. J. Pharm. Sci. 2013, 48, 64-71
173. Dora, C. L.; Silva, L. F.; Putaux, J. L.; Nishiyama, Y.; Pignot-Paintrand, I.; Borsali, R.; Lemos-Senna, E. Poly(ethylene glycol) hydroxystearate-based nanosized emulsions: Effect of surfactant concentration on their formation and ability to solubilize quercetin J. Biomed. Nanotechnol. 2012, 8, 202-210
174. Feng, R.; Song, Z.; Zhai, G. Preparation and in vivo pharmacokinetics of curcumin-loaded PCL-PEG-PCL triblock copolymeric nanoparticles Int. J. Nanomed. 2012, 7, 4089-4098
175. Scognamiglio, I.; De Stefano, D.; Campani, V.; Mayol, L.; Carnuccio, R.; Fabbrocini, G.; Ayala, F.; La Rotonda, M. I.; De Rosa, G. Nanocarriers for topical administration of resveratrol: A comparative study Int. J. Pharm. 2013, 440, 179-187
176. Lambert, J. D.; Kim, D. H.; Zheng, R.; Yang, C. S. Transdermal delivery of (-)-epigallo-catechin 3-gallate, a green tea polyphenol, in mice J. Pharm. Pharmacol. 2006, 58, 599-604
177. Hung, C. F.; Lin, Y. K.; Huang, Z. R.; Fang, J. Y. Delivery of resveratrol, a red wine polyphenol, from solutions and hydrogels via the skin Biol. Pharm. Bull. 2008, 31, 955-962
178. Quitschke, W. W. Differential solubility of curcuminoids in serum and albumin solutions: implications for analytical and therapeutic applications BMC Biotechnol. 2008, 8, 84
179. Ferry, D. R.; Smith, A.; Malkhandi, J.; Fyfe, D. W.; deTakats, P. G.; Anderson, D.; Baker, J.; Kerr, D. J. Phase I clinical trial of the flavonoid quercetin: Pharmacokinetics and evidence for in vivo tyrosine kinase inhibition Clin. Cancer Res. 1996, 2, 659-668
180. Bárcena, R.; Moreno, A.; Rodríguez-Gandía, M. A.; Albillos, A.; Arocena, C.; Blesa, C.; García-Hoz, F.; Graus, J.; Nuño, J.; López-Hervás, P.; Gajate, L.; Martínez, A.; Bermejo, T.; Mateos, M. L.; Del Campo, S. Hospital Ramón y Cajal Liver Transplant Group. Safety and anti-HCV effect of prolonged intravenous silibinin in HCV genotype 1 subjects in the immediate liver transplant period J. Hepatol. 2013, 58, 421-426
181. Scheepens, A.; Tan, K.; Paxton, J. W. Improving the oral bioavailability of beneficial polyphenols through designed synergies Genes Nutr. 2010, 5, 75-87
182. Green, R. J.; Murphy, A. S.; Schulz, B.; Watkins, B. A.; Ferruzzi, M. G. Common tea formulations modulate in vitro digestive recovery of green tea catechins Mol. Nutr. Food Res. 2007, 51, 1152-1162
183. Vert, M.; Doi, Y.; Hellwich, K. H.; Hess, M.; Hodge, P.; Kubisa, P.; Rinaudo, M.; Schué, F. Terminology for biorelated polymers and applications (IUPAC Recommendations 2012) Pure Appl. Chem. 2012, 84, 377-410
184. Bhardwaj, R. K.; Glaeser, H.; Becquemont, L.; Klotz, U.; Gupta, S. K.; Fromm, M. F. Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4 J. Pharmacol. Exp. Ther. 2002, 302, 645-650
185. Volak, L. P.; Ghirmai, S.; Cashman, J. R.; Court, M. H. Curcuminoids inhibit multiple human cytochromes P450, UDP-glucuronosyltransferase, and sulfotransferase enzymes, whereas piperine is a relatively selective CYP3A4 inhibitor Drug Metab. Dispos. 2008, 36, 1594-1605
186. Kidd, P.; Head, K. A review of the bioavailability and clinical efficacy of milk thistle phytosome: A silybin-phosphatidylcholine complex (Siliphos) Alternative Med. Rev. 2005, 10, 193-203
187. Sharma, A.; Gupta, N. K.; Dixit, V. K. Complexation with phosphatidyl choline as a strategy for absorption enhancement of boswellic acid Drug Deliv. 2010, 17, 587-595
188. Hüsch, J.; Bohnet, J.; Fricker, G.; Skarke, C.; Artaria, C.; Appendino, G.; Schubert-Zsilavecz, M.; Abdel-Tawab, M. Enhanced absorption of boswellic acids by a lecithin delivery form (Phytosome) of Boswellia extract Fitoterapia 2013, 84, 89-98
189. Mauri, P.; Simonetti, P.; Gardana, C.; Minoggio, M.; Morazzoni, P.; Bombardelli, E.; Pietta, P. Liquid chromatography/atmospheric pressure chemical ionization mass spectrometry of terpene lactones in plasma of volunteers dosed with Ginkgo biloba L. extracts Rapid Commun. Mass Spectrom. 2001, 15, 929-934
190. Rossi, R.; Basilico, F.; Rossoni, G.; Riva, A.; Morazzoni, P.; Mauri, P. L. Liquid chromatography/atmospheric pressure chemical ionization ion trap mass spectrometry of bilobalide in plasma and brain of rats after oral administration of its phospholipidic complex J. Pharm. Biomed. Anal. 2009, 50, 224-227
191. Liu, Z.; Wang, J.; Gao, W.; Man, S.; Guo, H.; Zhang, J.; Liu, C. Formulation and in vitro absorption analysis of Rhizoma paridis steroidal saponins Int. J. Pharm. 2013, 441, 680-686
192. Cole, E. T.; Cadé, D.; Benameur, H. Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration Adv. Drug Delivery Rev. 2008, 60, 747-756
193. Walle, T.; Hsieh, F.; DeLegge, M. H.; Oatis, J. E., Jr.; Walle, U. K. High absorption but very low bioavailability of oral resveratrol in humans Drug Metab. Dispos. 2004, 32, 1377-1382
194. Henry-Vitrac, C.; Desmoulière, A.; Girard, D.; Mérillon, J. M.; Krisa, S. Transport, deglycosylation, and metabolism of trans-piceid by small intestinal epithelial cells Eur. J. Nutr. 2006, 45, 376-382
195. Aggarwal, B. B.; Bhardwaj, A.; Aggarwal, R. S.; Seeram, N. P.; Shishodia, S.; Takada, Y. Role of resveratrol in prevention and therapy of cancer: Preclinical and clinical studies Anticancer Res. 2004, 24, 2783-2840
196. Henning, S. M.; Choo, J. J.; Heber, D. Nongallated compared with gallated flavan-3-ols in green and black tea are more bioavailable J. Nutr. 2008, 138, 1529S-1534S
197. Chadha, R.; Saini, A.; Arora, P.; Bhandari, S. Pharmaceutical cocrystals: a novel approach for oral bioavailability enhancement of drugs Crit. Rev. Ther. Drug Carrier Syst. 2012, 29, 183-218
198. Hoffmann, G. R. A perspective on the scientific, philosophical, and policy dimensions of hormesis Dose Response 2009, 7, 1-51
199. Mattson, M. P. Dietary factors, hormesis, and health Ageing Res. Rev. 2008, 7, 43-48
200. Hendrich, A. B. Flavonoid-membrane interactions: Possible consequences for biological effects of some polyphenolic compounds Acta Pharmacol. Sin. 2006, 27, 27-40
201. Hong, J.; Kwon, S. J.; Sang, S.; Ju, J.; Zhou, J. N.; Ho, C. T.; Huang, M. T.; Yang, C. S. Effects of garcinol and its derivatives on intestinal cell growth: Inhibitory effects and autoxidation-dependent growth-stimulatory effects Free Radic. Biol. Med. 2007, 42, 1211-1221
202. Maes, F.; de Keukeleire, D.; Heyerick, A. Production of hop extracts having oestrogenic and antiproliferative bioactivity. European Patent No. 1727555, 2009.
203. Thomasset, S. C.; Berry, D. P.; Garcea, G.; Marczylo, T.; Steward, W. P.; Gescher, A. J. Dietary polyphenolic phytochemicals-promising cancer chemopreventive agents in humans? A review of their clinical properties Int. J. Cancer. 2007, 120, 451-458
204. Arranz, S.; Valderas-Martinez, P.; Chiva-Blanch, G.; Casas, R.; Urpi-Sarda, M.; Lamuela-Raventos, R. M.; Estruch, R. Cardioprotective effects of cocoa: Clinical evidence from randomized clinical intervention trials in humans Mol. Nutr. Food Res. 2013, 57, 936-947
205. Takemura, H.; Sakakibara, H.; Yamazaki, S.; Shimoi, K. Breast cancer and flavonoids-A role in prevention Curr. Pharm. Des. 2013, 19, 6125-6132
206. van Dam, R. M.; Naidoo, N.; Landberg, R. Dietary flavonoids and the development of type 2 diabetes and cardiovascular diseases: Review of recent findings Curr. Opin. Lipidol. 2013, 24, 25-33
207. Shoji, Y.; Nakashima, H. Nutraceutics and delivery systems J. Drug Target. 2004, 12, 385-391
208. Luykx, D. M.; Peters, R. J.; van Ruth, S. M.; Bouwmeester, H. A review of analytical methods for the identification and characterization of nanodelivery systems in food J. Agric. Food Chem. 2008, 56, 8231-8247
209. Aillon, K. L.; Xie, Y.; El-Gendy, N.; Berkland, C. J.; Forrest, M. L. Effects of nanomaterial physicochemical properties on in vivo toxicity Adv. Drug Delivery Rev. 2009, 61, 457-466
210. Nahar, M.; Dutta, T.; Murugesan, S.; Asthana, A.; Mishra, D.; Rajkumar, V.; Tare, M.; Saraf, S.; Jain, N. K. Functional polymeric nanoparticles: An efficient and promising tool for active delivery of bioactives Crit. Rev. Ther. Drug Carrier Syst. 2006, 23, 259-318